Geographic · Non-Current Assets

UNITED STATES And PUERTO RICO — Non-Current Assets

Eli Lilly UNITED STATES And PUERTO RICO — Non-Current Assets increased by 40.0% to $18.76B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 40.0%, from $13.40B to $18.76B.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2018
Last reportedQ4 2025Feb 12, 2026
Rolls up toPP&E (Net)

How to read this metric

An increase suggests significant capital investment or expansion of manufacturing and research facilities in the region, while a decrease may indicate asset divestitures, depreciation, or a shift in capital allocation strategy.

Detailed definition

This metric represents the total value of long-term assets, such as property, plant, equipment, and intangible assets, a...

Peer comparison

Comparable to regional non-current asset disclosures in other multinational pharmaceutical companies, reflecting the geographic distribution of production and R&D infrastructure.

Metric ID: lly_segment_unitedstates_and_puertorico_noncurrent_assets

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$6.62B$7.71B$9.99B$13.40B$18.76B
QoQ Change+16.5%+29.6%+34.1%+40.0%
YoY Change+16.5%+29.6%+34.1%+40.0%
Range$6.62B$18.76B
CAGR+183.4%
Avg YoY Growth+30.0%
Median YoY Growth+31.9%
Current Streak4+ quarters growth

Frequently Asked Questions

What is Eli Lilly's united states and puerto rico — non-current assets?
Eli Lilly (LLY) reported united states and puerto rico — non-current assets of $18.76B in Q4 2025.
How has Eli Lilly's united states and puerto rico — non-current assets changed year-over-year?
Eli Lilly's united states and puerto rico — non-current assets increased by 40.0% year-over-year, from $13.40B to $18.76B.
What does united states and puerto rico — non-current assets mean?
The total value of long-term assets held by the company within its United States and Puerto Rico operations.